Poland Marks 85th Anniversary of Nazi Germany’s Invasion at Start of World War II

People lay a wreath at the monument to the 1939 heroic defense of the Westerplatte peninsula outpost during solemn observances of the 85th anniversary of the outbreak of World War II, at Westerplatte, on the Baltic Sea, Poland, on Sunday, Sept. 1, 2024. (AP)
People lay a wreath at the monument to the 1939 heroic defense of the Westerplatte peninsula outpost during solemn observances of the 85th anniversary of the outbreak of World War II, at Westerplatte, on the Baltic Sea, Poland, on Sunday, Sept. 1, 2024. (AP)
TT

Poland Marks 85th Anniversary of Nazi Germany’s Invasion at Start of World War II

People lay a wreath at the monument to the 1939 heroic defense of the Westerplatte peninsula outpost during solemn observances of the 85th anniversary of the outbreak of World War II, at Westerplatte, on the Baltic Sea, Poland, on Sunday, Sept. 1, 2024. (AP)
People lay a wreath at the monument to the 1939 heroic defense of the Westerplatte peninsula outpost during solemn observances of the 85th anniversary of the outbreak of World War II, at Westerplatte, on the Baltic Sea, Poland, on Sunday, Sept. 1, 2024. (AP)

Poland's leaders stressed the need for a strong defense in the face of war in neighboring Ukraine and redress as they led solemn ceremonies early Sunday to mark the 85th anniversary of German Nazi forces invading and bombing Polish territory at the start of World War II.

Sirens wailed and a memorial bell tolled as President Andrzej Duda and deputy ambassador of Germany, Robert Rohde, attended an observance in the town of Wielun, the first civilian target of German bombing in the small hours of Sept. 1, 1939. Some 1,200 people were killed in the attack which witnesses say began at 4:40 a.m.

"We can say that we have forgiven even though we remember, even though the pain is persisting and even though there are still tens of thousands of those who have been directly hurt by the Germans," Duda said. He also called on Berlin to make amends.

Meanwhile, at a monument on the Baltic Sea's Westerplatte peninsula, where a military outpost was shelled by a German warship just minutes after Wielun was attacked, Prime Minister Donald Tusk and Defense Minister Wladyslaw Kosiniak-Kamysz laid wreaths and attended a memorial roll call for fallen soldiers. At the time, the outpost's outnumbered troops fought for seven days before surrendering to the Germans, becoming a symbol of heroism and patriotism.

Tusk said war was present again in the region as the Russian invasion of Ukraine, which began in 2022, grinds on.

He said, in a clear reference to Germany, it wasn't enough to speak about "reconciliation" or to "bend your head in a sense of guilt," adding that the best sign of lessons learned from the past is "the readiness to organize the entire western world, Europe and NATO for the defense against aggression that we are witnessing today in the battlefields of Ukraine."

"Today we will not say ‘Neven Again.’ Today we must say ‘Never Again Alone’," the prime minister said.

Tusk also said Poland was building "the most modern army in Europe, one of the strongest in Europe" to actively contribute to the unity and strength of the NATO defense alliance and the European continent and "to defend our civilization" and "never again expose our homeland to any risks."

In more than five years of World War II and brutal German occupation, Poland lost 6 million citizens or a sixth of its population, of which 3 million were Jewish. The country also suffered huge losses to its infrastructure, industry and agriculture.

Poland's previous right-wing government demanded $1.3 trillion in damages from Germany. Tusk's current Cabinet has toned the demand down to some form of compensation that could serve to strengthen the ties between the two neighbors. Germany insists the matter is closed as it had paid damages to the Moscow-led East Bloc after the war. Warsaw says it did not get any share of it.

Addressing attendees at the Wielun observance, the Polish president said: "Forgiveness and the admission of guilt is one thing, but compensation for the damage caused is another thing. And this issue has not been settled yet."



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”